ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 1781 - 1800 of 2594 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Specifications, instrument reference on Koala small-molecule crystallography.
Mark Maley is a Senior Hydrometallurgist within the ANSTO Minerals Business Unit.
Tina is a Radiation Safety Training Educator within Radiation Services. She is responsible for the development, maintenance, and delivery of radiation safety courses to different facets of industry.
James Lowe is a Senior Chemical Engineer in the Pilot Plant Operations group within the ANSTO Minerals business unit and has over 13 years’ experience in the minerals industry.
Oleh Nakone has over 20 years’ experience in Executive Leadership roles within the Pharmaceutical and Health Care Industries.
Dr Rachel Williamson is a Principal Scientist on the MX Beamlines at the Australian Synchrotron.
On behalf of Australia, ANSTO, the only nuclear reactor facility in Australia, supports the International Atomic Energy Agency (IAEA) to undertake its role in facilitating national, regional, and international efforts to enhance nuclear security, including measures to protect against nuclear terrorism.
Australian-first detector to accelerate cancer research unveiled.
Nuclear security experts and officials from Australia’s nuclear agencies have convened at the International Atomic Energy Agency’s (IAEA) headquarters in Vienna, Austria last week for the International Conference on Nuclear Security (ICONS).